S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Preliminary Data From Ongoing Phase I/II Dose Escalation Study of TG-1101 (Ublituximab) in Combination With TGR-1202 in Heavily Pre-treated Relapsed/Refractory B-Cell Malignancies Demonstrates Encouraging Clinical Activity and Safety (2014/12/9)|
|Data From Phase 2 Clinical Trial of TG-1101 (Ublituximab) and Ibrutinib Shows Compelling Clinical Activity in Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL) (2014/12/8)|
|Park Electrochemical Corp. Announces Introduction of Meteorwave® 3000 and Meteorwave 4000, the Newest Members of the Meteorwave Product Family (2015/2/23)|
|TG Therapeutics, Inc. Announces Appointment of Kenneth Hoberman to Board of Directors (2014/12/17)|
|Asbury Automotive Group, Inc. Elects New Directors to Its Board (2015/1/9)|
|TVI Appoints Shirley Anthony as VP Corporate Communications (2015/2/2)|
|Tredegar Corporation Announces Webcast to Discuss 2014 Annual Financial Results (2015/2/20)|
|Tredegar Board Declares Dividend (2015/2/27)|
|TG Therapeutics Announces Collaboration for a Clinical Trial of TGR-1202 in Combination With Ibrutinib (Imbruvica(R)) for Patients With Select B-Cell Malignancies (2014/12/1)|
|TG Therapeutics, Inc. to Present at the 33rd Annual J.P. Morgan Healthcare Conference (2015/1/8)|
Click above to view more mutual fund data and stats for tgs - TGS-NOPEC Geophysical Co ASA.